Advocates have claimed that CVS’s refusal to cover Yeztugo violates the Affordable Care Act (ACA), which requires insurers to ...

CVS Health (NYSE:CVS), one of the leading health insurers in the U.S. and owner of the Pharmacy Benefit Manager Caremark, ...

CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory ...

In 2014, Caremark was accused of manipulating how drug costs were reported, prompting Aetna and SilverScript to submit false ...

CVS has emerged as an outlier during the ongoing implosion observed in the healthcare insurance sector, as they drive ...

CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to ...

We recently published 12 Latest Stocks On Jim Cramer’s Radar. CVS Health Corporation (NYSE:CVS) is one of the stocks Jim ...

The owner of the U.S.' largest pharmacy benefit manager is declining to cover Gilead Sciences’ long-acting HIV prevention ...

Primary care physicians and the state Senate’s health care point person are questioning a proposed partnership between Mass ...

A federal judge has ordered CVS Caremark to pay almost $290 million in damages and penalties after a whistleblower proved the ...

A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...

CVS Health Corp., parent of Hartford-based Aetna Inc., said Friday it has agreed to issue and sell $4 billion in notes.